When Standard PSMA Therapy Fails: Why Patients are Traveling Abroad for Alpha-Emitters (Actinium-225)
When PSMA-targeted therapy ceases to be effective, patients often experience a general shift: what once seemed like a stable treatment plan suddenly becomes uncertain. The disease continues to develop, and conventional options dry up, at which point people start seeking treatment that they cannot access at home. Germany has become one of the main targets […]









